US

Eisai, a pharmaceutical company, announced promising initial results in a clinical trial for an injectable version of the Alzheimer’s drug Leqembi. This development brings hope for a more convenient option for administering this antibody treatment. Currently, the approved method for administering Leqembi is through intravenous infusion. However, Eisai and its partner Biogen seek approval for
0 Comments
Taylor Swift has once again made headlines with her Eras Tour concert film, breaking records at the box office. This unique release has garnered attention and surpassed expectations, showcasing the power and influence of the pop star. A Strong Second Weekend Despite a 66% drop in ticket sales during its second weekend, the Eras Tour
0 Comments
The debate around net neutrality, the principle that all internet traffic should be treated equally without blocking or throttling, has resurfaced with renewed vigor. The Federal Communications Commission (FCC) recently voted in favor of initiating the process to reinstate the open internet rules, signaling a potential shift back to the safeguards established by the Obama
0 Comments
Unidentified flying objects, more commonly known as UFOs, have long fascinated the American public. For decades, UFO sightings have sparked the imaginations of people across the nation. However, the truth about these mysterious phenomena has remained elusive, and discussions have largely been relegated to the realm of science fiction. The absence of clear government statements
0 Comments